Mitchell S. Cairo, M.D.

New York Medical College

image of Mitchell Cairo

Mitchell S. Cairo is professor of pediatrics, medicine, pathology, microbiology and immunology and cell biology and anatomy, and associate chairman of the Department of Pediatrics at New York Medical College. He earned his medical degree at the the University of Wisconsin and University of California, San Francisco, and he completed a pediatric hematology/oncology fellowship at Indiana University. A researcher and a practicing physician, Dr. Cairo is also chief of pediatric hematology, oncology and stem cell transplantation, and director of the Children and Adolescent Cancer and Blood Diseases Center at Maria Fareri Children’s Hospital at Westchester Medical Center. His work focuses on cancer genetics, tumor immunology, transplantation biology, stem cell biology and regenerative medicine. 

Areas of Expertise

Pediatrics, genetics, and stem cell biology

Publications

  • Klejmont, L. M., Mo, X., Milner, J., Harrison, L., Morris, E., van de Ven, C., & Cairo, M. S. (2024). Risk Factors Associated With Survival Following Ganciclovir Prophylaxis Through Day +100 in Cytomegalovirus At-Risk Pediatric Allogeneic Stem Cell Transplantation Recipients: Development of Cytomegalovirus Viremia Associated With Significantly Decreased 1-Year Survival. Transplantation and Cellular Therapy, 30 (1), 103.e1-103.e8. https://doi.org/10.1016/j.jtct.2023.09.025
  • Perissinotti, A. J., Bishop, M. R., Bubalo, J., Geyer, M. B., Goodrich, A., Howard, S. C., Kula, J., Mandayam, S., Cairo, M. S., & Pui, C. (2023). Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel. Cancer Treatment Reviews, 120, 102603. https://doi.org/10.1016/j.ctrv.2023.102603
  • Klejmont, L. M., Mo, X., Milner, J., Harrison, L., Morris, E., van de Ven, C., & Cairo, M. S. (2023). Risk Factors Associated with Survival Following Ganciclovir Prophylaxis through Day +100 in Cytomegalovirus At-Risk Pediatric Allogeneic Stem Cell Transplantation Recipients: Development of CMV Viremia Associated with Significantly Decreased One-Year Survival. Transplantation and Cellular Therapy. https://doi.org/10.1016/j.jtct.2023.09.025
  • Cairo, M. S., Gallagher, J. R., Drea, E. J., Barnes, Y. J., Clark, C., & Carroll, S. (2023). Mortality After Rasburicase vs. Allopurinol Anti-Hyperuricemia Monotherapy in Patients With Liquid Tumors. Annals of Oncology, 34 (Suppl.2), S551-S552. https://doi.org/10.1016/j.annonc.2023.09.711
  • Kitko, C. L., Bollard, C. M., Cairo, M. S., Chewning, J., Fry, T. J., Pulsipher, M. A., Shenoy, S., Wall, D. A., & Levine, J. E. (2023). Children's Oncology Group's 2023 Blueprint for Research: Cellular Therapy and Stem Cell Transplantation. Pediatric Blood & Cancer, 70 Suppl 6 (Suppl 6), e30577. https://doi.org/10.1002/pbc.30577
  • Aggarwal, P., Luo, W., Pehlivan, K., Hoang, H., & Cairo, M. S. (2023). Targeting Glioblastoma & Diffuse Intrinsic Pontine Glioma w/Anti-Gd2 CAR Modified NK Cells. Pediatric Blood & Cancer, 70 (3), S5-S6. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/822
  • Persaud, N., Milner, J., Ayello, J., Chu, Y., Aguilar, M., Sturhahn, M., Fabricatore, S., Wolownik, K., McHale, P., Shaw, R., Morris, E., Harrison, L., Liu, D., Seiter, K., Steinberg, A., Flower, A., Van De Ven, C., Cairo, M. S., & Baxter-Lowe, L. (2023). Engraftment, Immune Reconstitution and Chimerism After CD34+Enriched With T-Cell Addback Transplant. Pediatric Blood & Cancer, 70, S192-S193. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/887
View All on Touro Scholar

Videos

Maria Ferrera Hospital director lauding NYMC research: